MedTrace Logo

Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea

NCT07015476 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2025-06-11

No results posted yet for this study

Summary

The study aims to evaluate the outcomes of different estrogen therapy regimens in patients with amenorrhea who face prolonged periods of hypoestrogenism.

The primary objective is to compare the outcomes on bone mass of different therapeutic regimens and identify more favorable. For this purpose, densitometry parameters such as BMD, T-score and Z-score at the level of the lumbar spine, femur and entire skeleton will be considered, comparing a bone densitometry (DXA technique, Dual X-ray Absorptiometry) Baseline with one carried out after at least one year of therapy. The secondary objective of the study is to assess other systemic/metabolic implications of the different therapies.

Conditions

  • Amenorrhea

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Maria C Meriggiola, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Min Age
15 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-09
Primary Completion
2025-10-31
Completion
2026-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07015476 on ClinicalTrials.gov